Showing results (51-60 of 692) with videos related to
Sort By:
Pageof 70
The American Journal of Psychiatry|December 1, 1980
Relationship of neuroleptic drug effects at brain dopamine, serotonin, alpha-adrenergic, and histamine receptors to clinical potencyS J Peroutka, S H SynderEuropean Journal of Pharmacology|April 12, 1989
Sumatriptan (GR 43175) interacts selectively with 5-HT1B and 5-HT1D binding sitesS J Peroutka, B G McCarthyAviation, Space, and Environmental Medicine|January 1, 1988
Differentiation of muscarinic cholinergic receptor subtypes in human cortex and pons: implications for anti-motion sickness therapyB G McCarthy, S J PeroutkaThe Journal of Clinical Psychiatry|April 1, 1990
Serotonin receptor and reuptake sites: pharmacologic significanceJ Gonzalez-Heydrich, S J PeroutkaMolecular Pharmacology|October 1, 1990
Quantitative molecular analysis predicts 5-hydroxytryptamine3 receptor binding affinityA W Schmidt, S J PeroutkaNeuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 1, 1990
Antagonist properties of d-LSD at 5-hydroxytryptamine2 receptorsP A Pierce, S J PeroutkaEuropean Journal of Pharmacology|January 3, 2001
The value of genotyping for apolipoprotein E alleles in relation to vitamin E supplementationS J Peroutka, D M DreonBrain Research|August 21, 1989
Distribution of cholecystokinin receptors in the dorsal vagal complex and other selected nuclei in the human medullaT M Hyde, S J PeroutkaMolecular Pharmacology|October 1, 1989
Three-dimensional steric molecular modeling of the 5-hydroxytryptamine3 receptor pharmacophoreA W Schmidt, S J PeroutkaThe Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 1, 1989
Differentiation of 5-hydroxytryptamine2 receptor subtypes using 125I-R-(-)2,5-dimethoxy-4-iodo-phenylisopropylamine and 3H-ketanserinD J McKenna, S J PeroutkaPageof 70